Skip to main content
. Author manuscript; available in PMC: 2014 Aug 5.
Published in final edited form as: Mol Pharm. 2013 Jul 11;10(8):2880–2890. doi: 10.1021/mp300729y

Fig. 8.

Fig. 8

Inhibitory effect of TPGS, PEG2K-VE, PEG2K-VE2, PEG5K-VE or PEG5K-VE2 on verapamil-stimulated P-gp ATPase activity. Test samples containing verapamil (50µM) and PEG-derivatized Vitamin E conjugates (final concentrations at 10 and 100 µM, respectively) or Na3VO4 (a selective inhibitor of P-gp) were incubated with P-gp membrane for 5 min at 37 °C. The reaction was initiated by the addition of MgATP followed by another 40 minutes’ incubation at 37°C. ATP detection reagent was then added luminescence was examined. *p < 0.05 and **p < 0.001 (vs TPGS of equivalent concentration). Values are reported as the means ± SD for triplicate samples.